Amgen submits Enbrel sBLA

AMGN submitted an sBLA to the FDA to support the once-weekly dosing of 50 mg Enbrel etanercept for rheumatoid arthritis (RA). The current recommended Enbrel dose for adults with RA or psoriatic arthri...